You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

acute myelogenous leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

Recruiting
  • Breast Cancer
  • +4 more
  • Web bases survey
  • Canton, Ohio
    Cleveland Clinic Mercy Hospital
Aug 2, 2023

Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

Recruiting
  • Acute Myelogenous Leukemia (AML) Due to Therapy
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Orange, California
  • +2 more
Nov 30, 2022

Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous

Recruiting
  • Breast Cancer
  • +4 more
  • Web based survey
  • New Haven, Connecticut
  • +6 more
Aug 8, 2023

Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

Completed
  • Acute Myelogenous Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 4, 2023

Acute Myelogenous Leukemia in Relapse, Acute Myelogenous Leukemia, Relapsed, Adult, Acute Myelogenous Leukemia, Adult Trial in

Terminated
  • Acute Myelogenous Leukemia in Relapse
  • +4 more
  • Tucson, Arizona
  • +12 more
Aug 18, 2022

LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of

Completed
  • Leukemia, Myelogenous, Acute
    • Charlotte, North Carolina
      Levine Cancer Institute
    Apr 19, 2022

    Acute Myeloid Leukemia Trial in Ramat Gan (CAR-T CD19)

    Recruiting
    • Acute Myeloid Leukemia
    • CAR-T CD19
    • Ramat Gan, Israel
      Chaim Sheba Medical Center
    Oct 30, 2022

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Gemtuzumab Ozogamicin
    • Valhalla, New York
      New York Medical College
    Sep 26, 2022

    Acute Myelogenous Leukemia (AML) Trial in Australia (MAX-40279)

    Recruiting
    • Acute Myelogenous Leukemia (AML)
    • Darlinghurst, New South Wales, Australia
    • +3 more
    Jan 18, 2022

    Acute Myelogenous Leukemia, MDS Trial in Shanghai (Gentulizumab)

    Recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndromes
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
    Feb 22, 2022

    MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)

    Active, not recruiting
    • Myelodysplastic Syndromes (MDS)
    • Acute Myelogenous Leukemia (AML)
    • low dose 5'-azacitidine
    • Basking Ridge, New Jersey
    • +6 more
    Dec 1, 2022

    AML, B-ALL, T-ALL Trial in Memphis (CD123-CAR T, Cyclophosphamide, Fludarabine)

    Recruiting
    • AML
    • +4 more
    • CD123-CAR T
    • +4 more
    • Memphis, Tennessee
    • +1 more
    May 10, 2022

    Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)

    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • AML
    • Kansas City, Kansas
    • +8 more
    Aug 3, 2022

    Acute Myelogenous Leukemia, Chronic Myelomonocytic Leukemia Trial in Tianjin (LILRB4 STAR-T cells injection)

    Not yet recruiting
    • Acute Myelogenous Leukemia
    • Chronic Myelomonocytic Leukemia
    • LILRB4 STAR-T cells injection
    • Tianjin, Tianjin, China
    • +1 more
    Feb 12, 2023

    Acute Myeloid Leukemia Trial in Birmingham (modified Geriatric Assessment (mGA))

    Completed
    • Acute Myeloid Leukemia
    • modified Geriatric Assessment (mGA)
    • Birmingham, Alabama
      University of Alabama Birmingham
    Jan 13, 2022

    Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Oklahoma City, Houston (Fenretinide,

    Terminated
    • Acute Myelogenous Leukemia
    • +2 more
    • Oklahoma City, Oklahoma
    • +1 more
    Mar 17, 2022

    Pediatric Acute Myelogenous Leukemia (AML) Trial in Australia, Canada, United States (Decitabine)

    Terminated
    Has Results
    • Pediatric Acute Myelogenous Leukemia (AML)
    • Phoenix, Arizona
    • +21 more
    Jun 24, 2022

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +12 more
    • Tucson, Arizona
      The University of Arizona Cancer Center
    Dec 13, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

    Not yet recruiting
    • Acute Myelogenous Leukemia
    • +17 more
    • Peripheral Blood Stem Cell Transplant
    • +7 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Mar 27, 2023

    Venetoclax Tablets Crushed and Dissolved Into a Solution

    Not yet recruiting
    • Hematologic Malignancy
    • +18 more
    • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Nov 8, 2023

    Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

    Completed
    Has Results
    • Myeloproliferative Disorders
    • +4 more
    • T-cell replete PBPC allograft
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 12, 2022

    High Risk Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston

    Completed
    • High Risk Myelodysplastic Syndrome
    • +2 more
    • Daratumumab
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 21, 2022

    AML Trial in Hangzhou (MAX-40279-01)

    Recruiting
    • AML
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital, Zhejiang University
    Jan 18, 2022

    Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +2 more
    • RD13-02 cell infusion
    • Xuzhou, Jiangsu, China
      Affiliated hospital of Xuzhou medical college
    Jun 7, 2023

    Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

    Recruiting
    • Acute Myelogenous Leukemia (AML)
    • +5 more
    • Conditioning Chemotherapy
    • Cord blood graft
    • Basking Ridge, New Jersey
    • +6 more
    May 22, 2023